Oscient Pharmaceuticals Announces Meeting Date for FDA Advisory Committee to Address sNDA for Five-Day Treatment of (Business Wire via Yahoo! Finance)
WALTHAM, Mass.----June 28, 2006--The U.S. Food and Drug Administration has informed Oscient Pharmaceuticals Corporation that the FDA's Anti-Infective Drugs Advisory Committee will review the supplemental New Drug Application for FACTIVE tablets for the treatment of acute bacterial sinusitis on September 12, 2006.

FDA Grants Swift Approval to New Leukemia Drug (HealthDay via Yahoo! News)
THURSDAY, June 29 (HealthDay News) -- U.S. regulators gave accelerated approval Wednesday to a new targeted therapy to treat people with chronic myeloid leukemia (CML).